An innovative training centre producing some of the UK’s most promising pharmaceutical talent is to forge ahead into a new phase after attracting almost £2 million in further funding.
The money will extend and grow the Centre for Doctoral Training in Targeted Therapeutics at the School of Pharmacy and will ensure it continues training research stars of the future until at least 2017.
The new award has come from the Engineering and Physical Sciences Research Council (EPSRC) and a consortium of industry leaders including Alliance Boots, AstraZeneca, GlaxoSmithKline, Pfizer, Critical Pharmaceuticals, Molecular Profiles and Quotient Clinical. It will also establish a new collaboration with UCL School of Pharmacy.
University of NottinghamUniversity Park Nottingham, NG7 2RD
For all enquiries please visit: www.nottingham.ac.uk/enquiry